{"component": "definition", "props": {"groups": [{"samples": [{"hash": "e82qMng58h3", "uri": "/contracts/e82qMng58h3#research-and-development-program", "label": "License Agreement (Endorex Corp)", "score": 18.0, "published": true}, {"hash": "6A6j9ppMvd9", "uri": "/contracts/6A6j9ppMvd9#research-and-development-program", "label": "License Agreement (Endorex Corp)", "score": 18.0, "published": true}, {"hash": "5FJkn6hTacU", "uri": "/contracts/5FJkn6hTacU#research-and-development-program", "label": "License Agreement (Endorex Corp)", "score": 18.0, "published": true}], "size": 7, "snippet_links": [{"key": "the-context", "type": "clause", "offset": [19, 30]}, {"key": "research-and-development-work", "type": "clause", "offset": [56, 85]}, {"key": "being-conducted", "type": "definition", "offset": [86, 101]}, {"key": "inter-alia", "type": "clause", "offset": [125, 135]}, {"key": "behalf-of-the-company", "type": "clause", "offset": [166, 187]}, {"key": "research-committee", "type": "definition", "offset": [219, 237]}, {"key": "approved-by", "type": "definition", "offset": [242, 253]}, {"key": "the-management-committee", "type": "clause", "offset": [254, 278]}], "snippet": "means depending on the context, one or more programs of research and development work being conducted or to be conducted by, inter alia, Orasomal and Elan for and on behalf of the Company which have been devised by the Research Committee and approved by the Management Committee;", "hash": "c7f12ae8a340033ffa4a95789f3af87b", "id": 1}, {"samples": [{"hash": "9VRog5yI0im", "uri": "/contracts/9VRog5yI0im#research-and-development-program", "label": "License Agreement (Isis Pharmaceuticals Inc)", "score": 18.0, "published": true}, {"hash": "6nkjUkijGZt", "uri": "/contracts/6nkjUkijGZt#research-and-development-program", "label": "License Agreement (Isis Pharmaceuticals Inc)", "score": 18.0, "published": true}, {"hash": "5ZQHP64w6Qg", "uri": "/contracts/5ZQHP64w6Qg#research-and-development-program", "label": "License Agreement (Targeted Genetics Corp /Wa/)", "score": 18.0, "published": true}], "size": 6, "snippet_links": [{"key": "same-meaning", "type": "clause", "offset": [15, 27]}, {"key": "the-development-agreement", "type": "clause", "offset": [50, 75]}], "snippet": "shall have the same meaning given to such term in the Development Agreement;", "hash": "d5fd1e305cc664eca3a650f1accc55f8", "id": 2}, {"samples": [{"hash": "fROvG6MIXnw", "uri": "/contracts/fROvG6MIXnw#research-and-development-program", "label": "Overview Agreement (Peptide Therapeutics Group PLC)", "score": 18.0, "published": true}, {"hash": "cI6CtT2VUd1", "uri": "/contracts/cI6CtT2VUd1#research-and-development-program", "label": "License Agreement (Oravax Inc /De/)", "score": 18.0, "published": true}, {"hash": "9zv0iqUtXyi", "uri": "/contracts/9zv0iqUtXyi#research-and-development-program", "label": "Overview Agreement (Peptide Therapeutics Group PLC)", "score": 18.0, "published": true}], "size": 4, "snippet_links": [], "snippet": "shall have the meaning set forth in Section 4.1(a).", "hash": "2e8f6d2fd4f2ede6c4439a0e1ebff7d3", "id": 3}, {"samples": [{"hash": "l4pSf05H03A", "uri": "/contracts/l4pSf05H03A#research-and-development-program", "label": "License Agreement (Emisphere Technologies Inc)", "score": 18.0, "published": true}, {"hash": "hqGaRyEPIQk", "uri": "/contracts/hqGaRyEPIQk#research-and-development-program", "label": "Research Collaboration and Option Agreement (Emisphere Technologies Inc)", "score": 18.0, "published": true}, {"hash": "5tb1ReJB4rg", "uri": "/contracts/5tb1ReJB4rg#research-and-development-program", "label": "Research Collaboration and Option Agreement (Emisphere Technologies Inc)", "score": 18.0, "published": true}], "size": 4, "snippet_links": [{"key": "joint-program", "type": "definition", "offset": [10, 23]}, {"key": "research-and-development-work", "type": "clause", "offset": [27, 56]}, {"key": "with-respect-to", "type": "clause", "offset": [58, 73]}, {"key": "the-field", "type": "definition", "offset": [74, 83]}, {"key": "the-product", "type": "clause", "offset": [88, 99]}, {"key": "being-conducted", "type": "definition", "offset": [101, 116]}, {"key": "inter-alia", "type": "clause", "offset": [140, 150]}, {"key": "for-and-on-behalf-of", "type": "clause", "offset": [172, 192]}, {"key": "parties-are", "type": "clause", "offset": [215, 226]}, {"key": "approved-by", "type": "definition", "offset": [274, 285]}, {"key": "the-steering-committee", "type": "definition", "offset": [286, 308]}, {"key": "the-research", "type": "clause", "offset": [310, 322]}, {"key": "work-for", "type": "definition", "offset": [365, 373]}, {"key": "clinical-trials", "type": "definition", "offset": [416, 431]}], "snippet": "means the joint program of research and development work, with respect to the Field and the Product, being conducted or to be conducted by, inter alia, Lilly and Emisphere for and on behalf of Lilly, for which both Parties are responsible, and which has been devised by and approved by the Steering Committee; the Research and Development Program shall not include work for which Lilly alone is responsible, such as clinical trials of Product(s);", "hash": "50e5e7bc11b4842c7809cbebced8a04f", "id": 4}, {"samples": [{"hash": "hk4xq2gcKyc", "uri": "/contracts/hk4xq2gcKyc#research-and-development-program", "label": "Research, Development and Licensing Agreement (Energy Ventures Inc /)", "score": 18.0, "published": true}, {"hash": "SySxuzc6OK", "uri": "/contracts/SySxuzc6OK#research-and-development-program", "label": "Research and Development Agreement (Lithium Technology Corp)", "score": 18.0, "published": true}, {"hash": "5fHj8zZhw8t", "uri": "/contracts/5fHj8zZhw8t#research-and-development-program", "label": "Agreement for Research, Development and Licensing of Technologies (Energy Ventures Inc /)", "score": 18.0, "published": true}], "size": 3, "snippet_links": [{"key": "the-research-program", "type": "clause", "offset": [6, 26]}], "snippet": "means the research program set forth in SCHEDULE B.", "hash": "1462a6f5435596a2f6083cee6bb7c6c5", "id": 5}, {"samples": [{"hash": "8n1hqPgGdOs", "uri": "/contracts/8n1hqPgGdOs#research-and-development-program", "label": "Collaboration Agreement", "score": 32.087317021, "published": true}, {"hash": "8iL1py4wbnz", "uri": "/contracts/8iL1py4wbnz#research-and-development-program", "label": "Collaboration Agreement (BioNTech SE)", "score": 31.5516769336, "published": true}], "size": 3, "snippet_links": [{"key": "the-program", "type": "clause", "offset": [6, 17]}, {"key": "collaboration-between-the-parties", "type": "clause", "offset": [21, 54]}, {"key": "to-develop", "type": "definition", "offset": [55, 65]}, {"key": "in-the-field", "type": "clause", "offset": [106, 118]}, {"key": "the-activities", "type": "clause", "offset": [130, 144]}, {"key": "research-and-development-plan", "type": "definition", "offset": [162, 191]}], "snippet": "means the program of collaboration between the Parties to Develop and Manufacture Candidates and Products in the Field, including the activities described in the Research and Development Plan.", "hash": "21221e1fd43d080837139fe75a02f909", "id": 6}, {"samples": [{"hash": "h1n7bmUTKAp", "uri": "/contracts/h1n7bmUTKAp#research-and-development-program", "label": "Termination Agreement (Elan Pharmaceutical Investments LTD)", "score": 18.0, "published": true}, {"hash": "dU9qnt0bxI6", "uri": "/contracts/dU9qnt0bxI6#research-and-development-program", "label": "Termination Agreement (Dor Biopharma Inc)", "score": 18.0, "published": true}], "size": 2, "snippet_links": [], "snippet": "shall have the meaning set forth in the JDOA.", "hash": "1daed1a51c5dcb1cb944d444ec1b6d88", "id": 7}, {"samples": [{"hash": "2z4cY4Axgdg", "uri": "/contracts/2z4cY4Axgdg#research-and-development-program", "label": "Management Agreement (American Superconductor Corp /De/)", "score": 18.0, "published": true}, {"hash": "9vJgBBzZIoO", "uri": "https://ir.amsc.com/static-files/a35506af-55eb-4884-9889-7033210fafcf", "label": "Amendment", "score": 13.2943189596, "published": false}], "size": 2, "snippet_links": [{"key": "directed-to", "type": "definition", "offset": [41, 52]}, {"key": "development-of", "type": "clause", "offset": [58, 72]}], "snippet": "means a research and development program directed to the \"development of HTS biaxially textured coated conductors.", "hash": "3af8ab90978f013ed0f5242b1c115d1d", "id": 8}, {"samples": [{"hash": "4eQU5wwOV0u", "uri": "/contracts/4eQU5wwOV0u#research-and-development-program", "label": "Development and Licensing Agreement (Pure Bioscience)", "score": 18.0, "published": true}, {"hash": "2k8cEGXvahN", "uri": "/contracts/2k8cEGXvahN#research-and-development-program", "label": "Development and Licensing Agreement (Pure Bioscience)", "score": 18.0, "published": true}], "size": 2, "snippet_links": [{"key": "research-and-development-activities", "type": "definition", "offset": [71, 106]}, {"key": "necessary-and-appropriate", "type": "definition", "offset": [114, 139]}, {"key": "from-time-to-time", "type": "clause", "offset": [151, 168]}, {"key": "development-of", "type": "clause", "offset": [177, 191]}, {"key": "the-development-plan", "type": "clause", "offset": [239, 259]}, {"key": "technology-development-plan", "type": "definition", "offset": [264, 291]}, {"key": "attached-hereto-as-exhibit", "type": "definition", "offset": [293, 319]}], "snippet": "or \"research and development program\" as used herein means any and all research and development activities deemed necessary and appropriate by the EMC from time to time for the development of SDC Product(s), and as more fully set forth in the Development Plan and Technology Development Plan, attached hereto as Exhibit B.", "hash": "e76340fc6397bb1911c8a875127984c6", "id": 9}, {"samples": [{"hash": "gKdoha9rOTa", "uri": "/contracts/gKdoha9rOTa#research-and-development-program", "label": "License Agreement (Coley Pharmaceutical Group, Inc.)", "score": 21.0, "published": true}, {"hash": "gBUNcUMsXET", "uri": "/contracts/gBUNcUMsXET#research-and-development-program", "label": "License Agreement (Coley Pharmaceutical Group, Inc.)", "score": 21.0, "published": true}], "size": 2, "snippet_links": [{"key": "the-research", "type": "clause", "offset": [6, 18]}, {"key": "directed-to", "type": "definition", "offset": [43, 54]}, {"key": "the-examination", "type": "clause", "offset": [55, 70]}, {"key": "mode-of-action", "type": "definition", "offset": [87, 101]}, {"key": "in-combination", "type": "definition", "offset": [102, 116]}, {"key": "licensed-antigen", "type": "definition", "offset": [122, 138]}, {"key": "the-context", "type": "clause", "offset": [176, 187]}, {"key": "the-field", "type": "definition", "offset": [223, 232]}], "snippet": "means the research and development program directed to the examination of the ADJUVANT mode of action in combination with LICENSED ANTIGEN within PRODUCT and/or COMBINATION in the context of THERAPEUTIC IMMUNIZATION within the FIELD. An outline of the RESEARCH AND DEVELOPMENT PROGRAM will be set forth in Appendix C.", "hash": "7078c9016c16b29435467ae82aaabe7b", "id": 10}], "next_curs": "Cm0SZ2oVc35sYXdpbnNpZGVyY29udHJhY3RzckkLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIpcmVzZWFyY2gtYW5kLWRldmVsb3BtZW50LXByb2dyYW0jMDAwMDAwMGEMogECZW4YACAA", "definition": {"size": 50, "title": "Research and Development Program", "snippet": "means depending on the context, one or more programs of research and development work being conducted or to be conducted by, inter alia, Orasomal and Elan for and on behalf of the Company which have been devised by the Research Committee and approved by the Management Committee;", "id": "research-and-development-program", "examples": ["Samples of compounds synthesized, purified or developed in the course of the <strong>Research and Development Program</strong> shall not be supplied or sent by either party to any Third Party, other than to regulatory agencies or for use in clinical trials, unless protected by an appropriate materials transfer agreement.", "Upon the occurrence of other significant events in the <strong>Research and Development Program</strong> or other activities hereunder, Emisphere and Lilly agree to make joint press releases.", "This program gives applicants opportunities to work together with other agencies to provide and maximize benefits (for example, the California Department of Food and Agriculture\u2019s Dairy Digester <strong>Research and Development Program</strong> and the California Department of Resources Recycling and Recovery\u2019s (CalRecycle) Organics Grant Program).", "Both Parties shall use reasonably diligent efforts, consistent with their efforts on other projects of similar commercial importance and state of development, to conduct their respective portions of the <strong>Research and Development Program</strong>.", "In conducting the <strong>Research and Development Program</strong>, each Party shall co-operate fully with the Steering Committee.", "The objectives of this initial phase of the <strong>Research and Development Program</strong> will be (a) to develop the Oral Platform, and (b) to develop the Development Product.", "Subject to the terms and conditions of this Agreement, ASTI shall have discretion to attempt to obtain, using Available Funds, any Proprietary Rights from any third party that ASTI reasonably determines to be necessary or useful to conduct any Product <strong>Research and Development Program</strong>, Pre-Selection Work or related activities under this Agreement.", "Each of the Parties will promptly notify the other in the event that any Third Party files any suit or brings any other action alleging patent infringement by Pfizer or BioNTech or any of their respective Affiliates or Sublicensees with respect to the Development, Manufacture, Commercialization or use of any Candidate or Product or the practice of any BioNTech Technology or <strong>Research and Development Program</strong> Technology (any such suit or other action referred to herein as an \u201cInfringement Claim\u201d).", "In the event that Licensee so requests, and subject to agreement by the parties hereto on the <strong>research and development program</strong> to be conducted in respect of any Licensed Product (each, a &quot;<strong>Research and Development Program</strong>&quot;), Licensor agrees to perform or have performed for the Licensee the Development Work set forth in any such <strong>Research and Development Program</strong>, and Licensee hereby agrees to fund the <strong>Research and Development Program</strong> in accordance with the terms and conditions set forth below.", "Each Party will promptly notify the other (through the Patent Committee) in the event of any actual, potential or suspected infringement of a patent under the BioNTech Patent Rights or <strong>Research and Development Program</strong> Patent Rights by any Third Party."], "related": [["research-and-development", "Research and development", "Research and development"], ["research-and-development-facility", "Research and development facility", "Research and development facility"], ["commercial-development-plan", "Commercial Development Plan", "Commercial Development Plan"], ["development-program", "Development Program", "Development Program"], ["clinical-development", "Clinical Development", "Clinical Development"]], "related_snippets": [], "updated": "2025-07-07T00:16:40+00:00"}, "json": true, "cursor": ""}}